Dr Manuela Klingler-Hoffmann is an experienced cell biologist and biochemist with a background in biophysics. Her passion in science is translational cancer research; the kind of research, which will make a positive impact to patient’s treatment and life expectancy. In 2018 she joined the Future Industries Institute, where she leads a small and dedicated team working on translational research projects in gynaecological cancers. Dr Manuela Klingler-Hoffmann has extensive experiences in a wide array of cell biology, proteomics and mass spectrometry techniques as well as in research design and project management. She is passionate about gender equity and was a member of the self-assessment team for SAGE... Read more
About me
Dr Manuela Klingler-Hoffmann is an experienced cell biologist and biochemist with a background in biophysics. Her passion in science is translational cancer research; the kind of research, which will make a positive impact to patient’s treatment and life expectancy. In 2018 she joined the Future Industries Institute, where she leads a small and dedicated team working on translational research projects in gynaecological cancers. Dr Manuela Klingler-Hoffmann has extensive experiences in a wide array of cell biology, proteomics and mass spectrometry techniques as well as in research design and project management. She is passionate about gender equity and was a member of the self-assessment team for SAGE (http://u.unisa.edu.au/about/sage-pilot).
After finishing her PhD in 1999 at the German Cancer Research Centre in Heidelberg, Germany, she has been awarded a prestigious DFG (German Research Foundation) fellowship to work at Monash University in Melbourne. After her time at Monash University, she has been working part time in several laboratories around the world and had a number of career interruptions. In 2016 she was the recipient of a Barbara Kidman Fellowship, which aims to enhance and promote the career of female academics. She has co-supervised more than a dozen Honour’s students and PhD students and numerous vacation scholarship students; with multiple winning internal and external awards, such as the University medal for best the PhD thesis in Biological Sciences.
About me
Doctor of Natural Sciences University of Saarland
Bachelor of Science in Biology University of Saarland
Research
Research since 2008 is shown below. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2019 |
Open access
5
1
2
|
| 2019 |
6
|
| 2019 |
Open access
3
|
| 2019 |
1
3
|
| 2018 |
Open access
7
5
1
|
| 2017 |
Open access
74
63
7
|
| 2017 |
10
9
1
|
| 2016 |
Open access
11
8
1
|
| 2016 |
11
9
10
|
| 2016 |
10
8
10
|
| 2016 |
Open access
3
3
4
|
| 2016 |
Open access
6
4
7
|
| 2015 |
4
3
|
| 2015 |
5
5
10
|
| 2014 |
31
30
31
|
| 2013 |
Open access
7
3
|
| 2013 |
Open access
35
29
1
|
| 2012 |
Open access
37
34
3
|
| 2012 |
24
22
4
|
| 2011 |
60
57
6
|
| 2010 |
5
5
|
| 2010 |
3
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Calistoga Pharmaceuticals Inc. | UNITED STATES |
| Chris O'Brien Lifehouse | AUSTRALIA |
| Griffith University | AUSTRALIA |
| Ludwig Institute for Cancer Research | AUSTRALIA |
| Macquarie University | AUSTRALIA |
| Murdoch Childrens Research Institute | AUSTRALIA |
| Queen Mary University of London | UNITED KINGDOM |
| Royal Adelaide Hospital | AUSTRALIA |
| Royal Prince Alfred Hospital | AUSTRALIA |
| SA Pathology | AUSTRALIA |
| Thammasat University | THAILAND |
| University of Adelaide | AUSTRALIA |
| University of Manchester | UNITED KINGDOM |
| University of Melbourne | AUSTRALIA |
| University of New South Wales | AUSTRALIA |
| University of Science, Malaysia | MALAYSIA |
| University of South Australia | AUSTRALIA |
| University of Washington | UNITED STATES |
| University of Western Australia | AUSTRALIA |
| Walter and Eliza Hall Institute of Medical Research | AUSTRALIA |
| Women's and Children's Hospital | AUSTRALIA |
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| Overcoming the hurdles of drug delivery for ovarian cancer: Preparation of targeted and pH-responsive nanoparticles loaded with Kinase and PARP Inhibitors. | Current |
